← brief for 2026-08-11 · Slowing decline

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Trial No results yet Not peer reviewed

Key takeaways

This is a new study, just starting, of a treatment called physiologic insulin resensitization for people who have both chronic kidney disease and type 2 diabetes. It aims to see whether carefully timed insulin dosing changes their outcomes. There are no results yet.

Who did this work

Run by Well Cell Global. Sungchun Lee, MD (Arizona Kidney Disease and Hypertension Centers)
Sites: Arizona Kidney Disease and Hypertension Center · Innovative Diabetic Center

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-04
https://clinicaltrials.gov/study/NCT07187479